The US Food and Drug Administration's Model-Informed Drug Development Meeting Program: From Pilot to Pathway
Clin Pharmacol Ther
.
2024 Mar 6.
doi: 10.1002/cpt.3228.
Online ahead of print.
Authors
Rajanikanth Madabushi
1
,
Jessica Benjamin
1
,
Hao Zhu
1
,
Issam Zineh
1
Affiliation
1
Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
PMID:
38445751
DOI:
10.1002/cpt.3228
No abstract available